Peer Review History
| Original SubmissionApril 14, 2020 |
|---|
|
Dear Dr Campbell, Thank you for submitting your manuscript entitled "Improved genetically encoded near-infrared fluorescent calcium ion indicators for in vivo imaging" for consideration as a Methods and Resources article by PLOS Biology. Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an Academic Editor with relevant expertise, and I am writing to let you know that we would like to send your submission out for external peer review. However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire. Please re-submit your manuscript within two working days, i.e. by Apr 21 2020 11:59PM. Login to Editorial Manager here: https://www.editorialmanager.com/pbiology During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit. Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review. Given the disruptions resulting from the ongoing COVID-19 pandemic, please expect delays in the editorial process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible. Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission. Kind regards, Gabriel Gasque, Ph.D., Senior Editor PLOS Biology |
| Revision 1 |
|
Dear Dr Campbell, Thank you very much for submitting your manuscript "Improved genetically encoded near-infrared fluorescent calcium ion indicators for in vivo imaging" for consideration as a Methods and Resources article at PLOS Biology. Your manuscript has been evaluated by the PLOS Biology editors, by an Academic Editor with relevant expertise, and by three independent reviewers. In light of the reviews (below), we will not be able to accept the current version of the manuscript, but we would welcome re-submission of a much-revised version that takes into account the reviewers' comments. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent for further evaluation by the reviewers. We expect to receive your revised manuscript within 2 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may end consideration of the manuscript at PLOS Biology. **IMPORTANT - SUBMITTING YOUR REVISION** Your revisions should address the specific points made by each reviewer. As you will see, the reviewers are overall very supportive. However, reviewers 2 and 3 indicate that additional experiments and controls would provide very useful information to the community. Considering this is a Resource, and having discussed these requests with the Academic Editor, we think that to strengthen the utility of these probes, you should address these points with additional data. Please submit the following files along with your revised manuscript: 1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript. *NOTE: In your point by point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point. You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response. 2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Related" file type. *Re-submission Checklist* When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: https://plos.io/Biology_Checklist To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record. Please make sure to read the following important policies and guidelines while preparing your revision: *Published Peer Review* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/ *PLOS Data Policy* Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5 *Blot and Gel Data Policy* We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Gabriel Gasque, Ph.D., Senior Editor PLOS Biology ***************************************************** REVIEWS: Reviewer #1: In general, compared to the conventional fluorescent calcium ion optogenetic tools and indicators functioned under visible wavelength light irradiation, the NIR genetically-encoded counterparts provide great advantages of reduced light toxicity, less background cross-talk with visible-light as well as decreased scattering and absorption in mammalian tissues. However, several disadvantages including lower brightness and limited fluorescence response remained the concerns to hamper their further applications for imaging of neuronal activity in vitro and in vitro. To overcome these technical barriers, in this study, qiao and co-authors genetically encoded two ca2+ indicators, NIR-GECO2 and NIR-GECO2G, to provide substantial improvements of neuronal imaging of Ca2+ dynamics in cultured cells, mouse brain slices, and C. elegans and Xenopus laevis in vivo. Even though some new challenges like less brightness, slower kinetics, and faster photobleaching still need to be further improved. Apparently, the authors have carried out extensive experiments and the manuscript has been well prepared. The referee thus supports the publication of this interesting study in Plos Biology as the current stage. Reviewer #2: In this manuscript by the Campbell lab (Qian et al), the authors described new variants of genetically encoded near-IR Ca2+ indicator NIR-GECO2 and NIR-GECO-2G. Compared to previously developed NIR-GECO1, there was not significant improvement in brightness or photo-stability, but they have 2-4 fold higher affinity to Ca2+. This increased dF / Fo of Ca2+ signals in neurons by 2-3 times. They showed that the new reagents are useful for Ca2+ imaging in acute slices, as well as in vivo imaging in C-elegans or Xenopus Laevis. Overall the improvement in Ca2+ sensitivity seems to be significant, and thus the reagent should be useful for the community. One significant concern is the lack of control experiments for the photo-conversion by blue light illumination (Fig. 2). Since they used channel rhodopsin to test the sensitivity of NIR-GECO in these experiments, I think it is important to report to what degree NIR-GECO shows photo-conversion by blue light. For the community, the degree of compatibility with channel rhodopsin would be a great interest too. Reviewer #3: Qian et al. reported development and in vivo demonstration of two improved near-infrared fluorescence calcium indicators. Compared to the parent sensor, NIR-GECO1, these two variants displayed increased affinity to calcium and about 3 to 4-fold higher ∆F/F in response to single-field stimuli in dissociated neuronal culture or light-stimuli (100ms) in the brain slice. Other intrinsic properties remain similar to NIR-GECO1. The improved sensitivity permitted populational imaging of optogenetically triggered or spontaneous neuronal activity in c.elegans and in Xenopus laevis, thus representing a substantial improvement compared to NIR-GECO1. The scope and novelty are appropriate to PLOS Biology. However, the authors should address/discuss a few points about in vivo utility of these sensors. 1. One of potential advantages using NIR-based probes is the depth penetration. In Fig 3 and 4, the authors nicely demonstrated calcium signals detected by NIR-GECO. It will significantly strengthen the utility of these probes if the authors compare the signal-to-noise ratio of NIR-GECO and jGCaMP/GCaMP and 3D volume/optical dissection depth possibly increased by using longer-wavelength. 2. The photostability is a major barrier for red-shifted calcium indicators. What is the highest acquisition rate of recording permitted without significant photobleaching, 2Hz? Can the same neuronal population be imaged repeatedly without significant photobleaching? 3. In Fig 3, the authors co-expressed HO1 to enhance the BV level in neurons. However, the authors did not mention the fold-increase in terms of brightness without HO1 co-expression. 4. It is not clear whether co-expression with jRCaMP or GCaMP6s would influence the expression level of NIR-GECO2/2G. In Fig 3a and 4b, the express patterns of two sensors are not exactly the same. Can authors clarify whether co-expression of another sensor would influence the expression and performance of NIR-GECO? 5. In Fig 3b and Fig 4c, the waveform of jGCaMP7 or GCaMP6s is not exactly the same with that of NIR-GECO2. For example, there is a mall transient right before the third puff of NaCl detected by jGCaMP7, but not by NIR-GECO2. Is this due to the sensitivity of the sensor. In Fig 4c, the fluorescence signal of NIR-GECO2G seems to lag behind GCaMP6s. it requires some discussion about the discrepancy of calcium signals detected by different sensors. 6. As there is no in vivo demonstration in rodent, I assume it remains challenging to image neuronal activity with NIR-GECO2 in rodents. Can the authors discuss the challenges/limitations preventing the use of these variants in rodents? 7. The authors nicely demonstrated that the sensor can be targeted to nucleus in Fig 3. Though it may not be useful for in vivo imaging, it will be useful to use 2 or 3 colors to detect calcium transients in various subcellular locations. This could be a good discussion point about usefulness of these probes. |
| Revision 2 |
|
Dear Dr Campbell, Thank you for submitting your revised Methods and Resources article entitled "Improved genetically encoded near-infrared fluorescent calcium ion indicators for in vivo imaging" for publication in PLOS Biology. I have now obtained advice from the original reviewers 2 and 3 and have discussed their comments with the Academic Editor. You will note that reviewer 3, Lin Tian, has revealed her identity. Please accept my apologies for the delay in communicating this decision to you. We're delighted to let you know that we're now editorially satisfied with your manuscript. However before we can formally accept your paper and consider it "in press", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can't proceed until these requirements are met, your swift response will help prevent delays to publication. Please also make sure to address the data and other policy-related requests noted at the end of this email. To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following: - a cover letter that should detail your responses to any editorial requests, if applicable - a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable) - a track-changes file indicating any changes that you have made to the manuscript. *Copyediting* Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript. NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines: https://journals.plos.org/plosbiology/s/supporting-information *Published Peer Review History* Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/ *Early Version* Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article. *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods Please do not hesitate to contact me should you have any questions. Sincerely, Gabriel Gasque, Ph.D., Senior Editor, PLOS Biology ------------------------------------------------------------------------ ETHICS STATEMENT: -- Please include in your manuscript the ID numbers of the protocols approved by the Massachusetts Institute of Technology Committee on Animal Care and by the the Montreal Neurological Institute Animal Care Committee. ------------------------------------------------------------------------ DATA POLICY: You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797 Note that we do not require all raw data. Rather, we ask for all individual quantitative observations that underlie the data summarized in the figures and results of your paper. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5 These data can be made available in one of the following forms: 1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore). 2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication. Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels: Figures 1b-e, 2a-d, 3bce, 4a-e, S2abde, S3ab, and S5a-d. NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values). Please also ensure that each figure legend in your manuscript includes information on where the underlying data can be found and that your supplemental data file/s has/have a legend. Please ensure that your Data Statement in the submission system accurately describes where your data can be found. ------------------------------------------------------------------------ BLOT AND GEL REPORTING REQUIREMENTS: For manuscripts submitted on or after 1st July 2019, we require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements ------------------------------------------------------------------------ Reviewer remarks: Reviewer #2: All concerns are addressed. Reviewer #3, Lin Tian: The authors have thoroughly addressed my conners. I believe NIR-GECO2 is a valuable tool to the field and should be published and disseminated asap. |
| Revision 3 |
|
Dear Dr Campbell, On behalf of my colleagues and the Academic Editor, Polina V. Lishko, I am pleased to inform you that we will be delighted to publish your Methods and Resources in PLOS Biology. PRODUCTION PROCESS Before publication you will see the copyedited word document (within 5 business days) and a PDF proof shortly after that. The copyeditor will be in touch shortly before sending you the copyedited Word document. We will make some revisions at copyediting stage to conform to our general style, and for clarification. When you receive this version you should check and revise it very carefully, including figures, tables, references, and supporting information, because corrections at the next stage (proofs) will be strictly limited to (1) errors in author names or affiliations, (2) errors of scientific fact that would cause misunderstandings to readers, and (3) printer's (introduced) errors. Please return the copyedited file within 2 business days in order to ensure timely delivery of the PDF proof. If you are likely to be away when either this document or the proof is sent, please ensure we have contact information of a second person, as we will need you to respond quickly at each point. Given the disruptions resulting from the ongoing COVID-19 pandemic, there may be delays in the production process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible. EARLY VERSION The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. PRESS We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf. We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/. Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process. Kind regards, Vita Usova Publication Editor, PLOS Biology on behalf of Gabriel Gasque, Senior Editor PLOS Biology |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .